Wealth Enhancement Advisory Services
ASTH icon

Wealth Enhancement Advisory Services’s Astrana Health ASTH Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$31.1K Buy
160,362
+137,905
+614% +$5.44M ﹤0.01% 4085
2026
Q2 		$27.7K Buy
+22,457
New +$808K ﹤0.01% 4003
2026
Q1 		– Sell
-695
Closed -$285K – 3894
2025
Q4 		$285K Buy
695
+435
+167% +$11.6K ﹤0.01% 2966
2025
Q3 		$7.89K Buy
+260
New +$7.05K ﹤0.01% 3567

Other funds holding ASTH

SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Insight Wealth Strategies
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
Linden Thomas Advisory Services
Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Wealth Enhancement Advisory Services's ASTH Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its Astrana Health (ASTH) stake by 614% in Q3 2026, buying an estimated $5.44M and bringing the position to 160,362 shares worth $31.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4085.

Wealth Enhancement Advisory Services first reported a position in ASTH in Q3 2025 and has held it in 4 quarters since. The position peaked at $285K in Q4 2025. 35 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Wealth Enhancement Advisory Services held 160,362 shares of Astrana Health worth $31.1K as of Q3 2026.
  • Wealth Enhancement Advisory Services bought 137,905 Astrana Health shares in Q3 2026, an estimated $5.44M.
  • Astrana Health made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #4085 holding.
  • Wealth Enhancement Advisory Services first reported a position in Astrana Health in Q3 2025 and has held it in 4 quarters since.
  • Wealth Enhancement Advisory Services's Astrana Health position peaked at $285K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.